5434 news items
Page 5 of 100
ofo3c1hmr2fmg5wr3jf029gv7crdwzx 5isenwvh63
VRT
31 May 24
recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q for a discussion of these and other important risk factors concerning
nv9zr9phpnqv1he
YUMC
31 May 24
-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results
hkp sv2qma6y4s51ox6mz9ypl27s6h8488x941ir59mr3tak5d7jtnfqv
ABBV
31 May 24
Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation, and specifically declines, to release publicly
k825kshwztruptb6r p7hl47okqjeh29iwiczld
REGN
31 May 24
filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2023 and its Form 10-Q for the quarterly
oyyc63on01jttnpeqf29rmgujpo77
REGN
31 May 24
with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2023 and its Form 10-Q for the quarterly period
6j7k34gv7
REGN
31 May 24
. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2023 and its Form 10-Q for the quarterly period ended March 31
4jyxz699e5qhqljtdig1gfsa91vo
REGN
31 May 24
and its Form 10-Q for the quarterly period ended March 31, 2024. Any forward-looking statements are made based on management's current beliefs
ltzviqjmiao2sig5mnp x5f
30 May 24
in China and overcoming cultural barriers, International Regulatory Agencies Updates and Q
tvhxi3vp
RVPH
30 May 24
September 30, 2022 included in its Quarterly Report on Form 10-Q, and each of the interim financial statements for the quarterly
ijb4a6nm8tb934jwn24jhbw2w g5vv093
ARHS
30 May 24
condensed consolidated financial statements included in Amendment No. 1 to the Company's Quarterly Report on Form 10-Q/A for the period ended
olfq8lf6am08b1aam41euc2yrg0aa2bz0 b38iahvgrb34gfffm1yhq
ELS
30 May 24
December 31, 2022 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the ‘Prior Period Financial Statements')." Equity LifeStyle
hdiei2jegaj17cmvil1owmxq4
JSPR
30 May 24
Reports on Form 10-Q. If any of these risks materialize or Jasper's assumptions prove incorrect, actual results could differ materially from
e9byqiv
BPMC
30 May 24
Blueprint Medicines' most recent Annual Report on Form 10-K, as supplemented by its most recent Quarterly Report on Form 10-Q and any other filings
p7250w
HCP
30 May 24
Annual Report on Form 10-K dated March 20, 2024, Quarterly Report on Form 10-Q dated May 30, 2024, and our future reports that we may file from time
59z8kzg5mpl6tg0n4m4q18n3zb2hosyzn4js708 rll0cshqb2jl6xpuvv
AESI
30 May 24
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Readers are cautioned not to place undue reliance on forward-looking statements, which
4uazyy1
CAUD
30 May 24
regarding the timely filing of its quarterly report on Form 10-Q for the quarter ended March 31, 2024. The company has until June 24, 2024, to submit a plan
irsai8dhcys pvenqc7
BFI
30 May 24
subsequent Quarterly Reports on Form 10-Q, and those discussed in other documents we file with the Securities and Exchange Commission, including our ability
binsxwotk2z89wez4060u62eft1nabe2nzre96cqz
VNDA
30 May 24
of Operations" sections of Vanda's most recent Annual Report on Form 10-K, as updated by Vanda's subsequent Quarterly Reports on Form 10-Q
lugv2k7icat 5e0krw0iimkg5z7cr2g
OCX
30 May 24
dosing intervals and duration of anti-rejection therapy." Up to 20.2% of kidney transplant patients will develop AMR within 10
8q3r2laz4tm0gwifi2dxicu6kb8ztvrqx60nyphj 53668kzv
ADSK
30 May 24
The Class Period begins on June 1, 2023, when Autodesk filed with the SEC its quarterly report on Form 10-Q for the period ended April 30, 2023